Latest stories on MLTX
MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on FDA Progress
Yahoo Top61 · neutralanalyst
MoonLake Secures Long-Term Manufacturing Capacity with Vetter Pharma
TipRanks61 · neutralproduct/pr
MoonLake (MLTX) Shares Gain After Positive FDA Meeting on Sonelokimab Filing
Yahoo Top67 · bullishproduct/pr